Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAVATO 200 vs Entresto bioequivalence study in healthy adults under fasting conditions
TCTR20260108003Phase 1Completed
- Sponsor
- Dr.porranee puranajoti
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of sacubitril + valsartan (2 arms), sponsored by Dr.porranee puranajoti. Primary endpoint: Pharmacokinetic parameters of sacubitril and valsartan. Started Jan 2026; status: completed.
02
Drugs
sacubitril + valsartan
Beyond the preview
Go deeper on TCTR20260108003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260108003.